Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 901 AL 915

Retrograde Axonal Degeneration in Parkinson Disease

Tagliaferro P, Burke RE.

J Parkinsons Dis. 2016;6(1):1-15. doi: 10.3233/JPD-150769.

Evolution of visual art with dopaminergic therapy

Walker RH.

J Clin Mov Disord. 2016 Mar 21;3:6. doi: 10.1186/s40734-016-0034-y. eCollection 2016.

Recurrence of dyskinesia as a side-effect of mirabegron in a patient with Parkinson's disease on DBS (GPi)

Murchison AG, Fletcher C, Cheeran B.

Parkinsonism Relat Disord. 2016 Jun;27:107-8. doi: 10.1016/j.parkreldis.2016.03.009. Epub 2016 Mar 16.

[Neurorehabilitation in Parkinson's disease]

Möller JC, Menig A, Oechsner M.

Praxis (Bern 1994). 2016 Mar 30;105(7):377-82. doi: 10.1024/1661-8157/a002306.

Non-oral Continuous Drug Delivery Techniques in Parkinson's Disease: For Whom, When, and How?

Timpka J, Henriksen T, Odin P.

Mov Disord Clin Pract. 2016 Mar 24;3(3):221-229. doi: 10.1002/mdc3.12303. eCollection 2016 May-Jun.

Longitudinal changes in cognition in early Parkinson's disease patients with REM sleep behavior disorder

Chahine LM, Xie SX, Simuni T, Tran B, Postuma R, Amara A, Oertel WH, Iranzo A, Scordia C, Fullard M, Linder C, Purri R, Darin A, Rennert L, Videnovic A, Del Riva P, Weintraub D.

Parkinsonism Relat Disord. 2016 Jun;27:102-6. doi: 10.1016/j.parkreldis.2016.03.006. Epub 2016 Mar 12.

Pharmacological interventions for daytime sleepiness and sleep disorders in Parkinson's disease: Systematic review and meta-analysis

Rodrigues TM, Castro Caldas A, Ferreira JJ.

Parkinsonism Relat Disord. 2016 Jun;27:25-34. doi: 10.1016/j.parkreldis.2016.03.002. Epub 2016 Mar 4.

Research in Parkinson's disease in India: A review

Surathi P, Jhunjhunwala K, Yadav R, Pal PK.

Ann Indian Acad Neurol. 2016 Jan-Mar;19(1):9-20. doi: 10.4103/0972-2327.167713.

Nurr1-Based Therapies for Parkinson's Disease

Dong J, Li S, Mo JL, Cai HB, Le WD.

CNS Neurosci Ther. 2016 May;22(5):351-9. doi: 10.1111/cns.12536. Epub 2016 Mar 25.

Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms

Felice VD, Quigley EM, Sullivan AM, O'Keeffe GW, O'Mahony SM.

Parkinsonism Relat Disord. 2016 Jun;27:1-8. doi: 10.1016/j.parkreldis.2016.03.012. Epub 2016 Mar 16.

Spinal Cord Lesion by Minor Trauma as an Early Sign of Multiple System Atrophy

Brum M, Reimão S, Sousa D, de Carvalho R, Ferreira JJ.

Front Neurol. 2016 Mar 14;7:33. doi: 10.3389/fneur.2016.00033. eCollection 2016.

Engineering and Evolution of Molecular Chaperones and Protein Disaggregases with Enhanced Activity

Mack KL, Shorter J.

Front Mol Biosci. 2016 Mar 15;3:8. doi: 10.3389/fmolb.2016.00008. eCollection 2016.

CSF biomarkers in neurodegenerative and vascular dementias

Llorens F, Schmitz M, Ferrer I, Zerr I.

Prog Neurobiol. 2016 Mar-May;138-140:36-53. doi: 10.1016/j.pneurobio.2016.03.003. Epub 2016 Mar 22.

[Impulse control disorders associated with dopaminergic agonists in Parkinson's disease. Case report]

Gamboa Arango A, Bernal Bernal MT, Duaso Magaña E.

Rev Esp Geriatr Gerontol. 2016 Sep-Oct;51(5):304-5. doi: 10.1016/j.regg.2016.01.010. Epub 2016 Mar 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias